1187594-13-3 Usage
Description
2-(1-(ethylsulfonyl)-3-(4-(7-((2-(trimethylsilyl)ethoxy)methyl)-7H-pyrrolo[2,3-d]pyrimidin-4-yl)-1H-pyrazol-1-yl)azetidin-3-yl)acetonitrile is a highly complex chemical compound with a multitude of functional groups and elements. It features a pyrrolopyrimidine core, which is common in biologically active molecules, and also contains a pyrazole ring and an azetidine ring. Additionally, this molecule includes an ethylsulfonyl group, a trimethylsilyl group, a nitrile group, and an ether group. Other notable features are a silyl ether and an ethyl sulfone. Despite its intricate structure, there is limited information available on the specific properties, chemistry, or potential applications of this compound.
Uses
As the provided materials do not specify any particular applications for 2-(1-(ethylsulfonyl)-3-(4-(7-((2-(trimethylsilyl)ethoxy)methyl)-7H-pyrrolo[2,3-d]pyrimidin-4-yl)-1H-pyrazol-1-yl)azetidin-3-yl)acetonitrile, it is not possible to list its uses based on the information given. However, given the presence of various functional groups, it can be hypothesized that this compound may have potential applications in fields such as pharmaceuticals, materials science, or as an intermediate in the synthesis of other complex molecules. Further research and experimentation would be required to determine its specific uses and properties.
Check Digit Verification of cas no
The CAS Registry Mumber 1187594-13-3 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,1,8,7,5,9 and 4 respectively; the second part has 2 digits, 1 and 3 respectively.
Calculate Digit Verification of CAS Registry Number 1187594-13:
(9*1)+(8*1)+(7*8)+(6*7)+(5*5)+(4*9)+(3*4)+(2*1)+(1*3)=193
193 % 10 = 3
So 1187594-13-3 is a valid CAS Registry Number.
1187594-13-3Relevant articles and documents
AZETIDINE DERIVATIVE, PREPARATION METHOD THEREFOR, AND USE THEREOF
-
Paragraph 0125; 0126, (2018/08/29)
The present invention relates to an azetidine derivative for use as a Janus kinase (JAK) inhibitor, a drug composition comprising same, a preparation method therefor, and a use thereof in the treatment of JAK-related diseases comprising, for example, infl
AZETIDINE AND CYCLOBUTANE DERIVATIVES AS JAK INHIBITORS
-
Page/Page column 64, (2009/09/28)
The present invention relates to azetidine and cyclobutane derivatives, as well as their compositions, methods of use, and processes for preparation, which are JAK inhibitors useful in the treatment of JAK-associated diseases including, for example, inflammatory and autoimmune disorders, as well as cancer.
